David F. Penson

Articles in Scholarly Journals [Incomplete List]

  1. PSA Screening and Elderly Men
    JAMA: The Journal of the American Medical Association, vol. 297, no. 9, pp. 949–949, 2007
  2. Radical Cystectomy With Extended Lymphadenectomy: Evaluating Separate Package Versus en Bloc Submission for Node Positive Bladder Cancer
    The Journal of Urology, vol. 177, no. 3, pp. 876–882, 2007
  3. 13-Year Outcomes Following Treatment for Clinically Localized Prostate Cancer in a Population Based Cohort
    The Journal of Urology, vol. 177, no. 3, pp. 932–936, 2007
  4. Predictors of Overall and Cancer-Free Survival of Patients With Localized Prostate Cancer Treated With Primary Androgen Suppression Therapy: Results From the Prostate Cancer Outcomes Study
    The Journal of Urology, vol. 177, no. 4, pp. 1307–1312, 2007
  5. Race/Ethnicity, Obesity, Health Related Behaviors and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
    The Journal of Urology, vol. 177, no. 4, pp. 1395–1400, 2007
  6. Editorial Comment
    The Journal of Urology, vol. 177, no. 4, pp. 1275–1276, 2007
  7. Editorial Comment
    The Journal of Urology, vol. 177, no. 4, pp. 1425–1425, 2007
  8. Editorial Comment
    The Journal of Urology, vol. 177, no. 5, pp. 1714–1714, 2007
  9. Prostate Cancer
    The Journal of Urology, vol. 177, no. 6, pp. 2020–2029, 2007
  10. On the Importance of Race, Socioeconomic Status and Comorbidity When Evaluating Quality of Life in Men With Prostate Cancer
    The Journal of Urology, vol. 177, no. 6, pp. 1992–1999, 2007
  11. Pay for Performance: Rationale and Potential Implications for Urology
    The Journal of Urology, 2007
  12. Socioeconomic Factors, Urological Epidemiology and Practice Patterns
    The Journal of Urology, 2007
  13. Trends in Treatment Costs for Localized Prostate Cancer
    Medical Care, vol. 45, no. 2, pp. 154–159, 2007
  14. Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other?
    BJU International, vol. 98, no. 1, pp. 105–109, 2006
  15. Editorial comment
    The Journal of Urology, vol. 175, no. 5, pp. 1704–1705, 2006
  16. Editorial comment
    The Journal of Urology, vol. 175, no. 5, pp. 1835–1835, 2006
  17. Discussing quality-of-life issues with a patient newly diagnosed with prostate cancer
    Nature Clinical Practice Urology, vol. 3, no. 8, Article ID ncpuro0562, 3 pages, 2006
  18. The Effectiveness of Screening for Prostate Cancer: A Nested Case-Control Study
    Archives of Internal Medicine, vol. 166, no. 1, pp. 38–43, 2006
  19. Why do men choose one treatment over another?
    Cancer, vol. 106, no. 9, pp. 1865–1874, 2006
  20. Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: Results of a nationwide survey of urologists
    Urology, vol. 68, no. 1, pp. 80–84, 2006
  21. Health-related quality of life for men with prostate cancer and diabetes: A longitudinal analysis from CaPSURE
    Urology, vol. 68, no. 6, pp. 1242–1247, 2006
  22. Health outcomes in older men with localized prostate cancer: Results from the Prostate Cancer Outcomes StudyHoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM, Medicine Service, New Mexico VA Health Care System, Albuquerque, NM
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 5, pp. 457–457, 2006
  23. Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinomaCanada AL, Neese LE, Sui D, Schover LR, Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 5, pp. 458–458, 2006
  24. Quality of life in prostate cancer patients taking androgen deprivation therapyDacal K, Sereika SM, Greenspan SL, School of Medicine, University of Pittsburgh, Pittsburgh, PA
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 5, pp. 458–459, 2006
  25. Quality of life in long-term survivors of bladder cancerAllareddy V, Kennedy J, West MM, Konety BR, Department of Urology, University of Iowa, Iowa City, IA
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 5, pp. 459–460, 2006
  26. Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better?Konety BR, Allareddy V, Modak S, Smith B, Department of Urology, Carver College of Medicine and College of Public Health, University of Iowa, Iowa City, IA
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 5, pp. 460–460, 2006
  27. Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer
    International Journal of Radiation OncologyBiologyPhysics, vol. 66, no. 2, pp. 395–402, 2006
  28. Salvage Radical Prostatectomy: Quality of Life Outcomes and Long-Term Oncological Control of Radiorecurrent Prostate Cancer
    The Journal of Urology, vol. 176, no. 5, pp. 2025–2032, 2006
  29. Editorial Comment
    The Journal of Urology, vol. 176, no. 6, pp. 2598–2598, 2006
  30. Prostate Cancer on the Internetâ??Information or Misinformation?
    The Journal of Urology, vol. 175, no. 5, pp. 1836–1842, 2006
  31. Clinical and Psychosocial Characteristics of Men with Erectile Dysfunction: Baseline Data from ExCEED?
    The Journal of Sexual Medicine, vol. 3, no. 6, pp. 1059–1067, 2006
  32. Longitudinal Differences in Psychological Outcomes for Men with Erectile Dysfunction: Results from ExCEEDTM
    The Journal of Sexual Medicine, vol. 3, no. 6, pp. 1068–1076, 2006
  33. Variations in Prostate Cancer Patterns of Care: Is It the Quality of Care or the Quality of the Data?
    Journal of Clinical Oncology, vol. 23, no. 31, pp. 7783–7784, 2005
  34. Quality of life in patients with localized prostate cancer
    Urologic Oncology: Seminars and Original Investigations, vol. 23, no. 3, pp. 208–215, 2005
  35. An update on randomized clinical trials in localized and locoregional prostate cancer
    Urologic Oncology: Seminars and Original Investigations, vol. 23, no. 4, pp. 280–288, 2005
  36. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer
    The American Journal of Medicine, vol. 118, no. 8, pp. 850–857, 2005
  37. Quality of Life Issues in Bladder Cancer Patients Following Cystectomy and Urinary Diversion
    Urologic Clinics of North America, vol. 32, no. 2, pp. 207–216, 2005
  38. Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?
    Urology, vol. 66, no. 4, pp. 835–839, 2005
  39. Prostate Cancer and the Will Rogers Phenomenon
    CancerSpectrum Knowledge Environment, vol. 97, no. 17, pp. 1248–1253, 2005
  40. HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND CRITICAL ANALYSIS OF THE LITERATURE
    The Journal of Urology, vol. 173, no. 4, pp. 1318–1322, 2005
  41. THE RELATIONSHIP AMONG LOWER URINARY TRACT SYMPTOMS, PROSTATE SPECIFIC ANTIGEN AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: RESULTS FROM THE PROSCAR LONG-TERM EFFICACY AND SAFETY STUDY
    The Journal of Urology, vol. 173, no. 3, pp. 903–907, 2005
  42. 5-YEAR URINARY AND SEXUAL OUTCOMES AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE PROSTATE CANCER OUTCOMES STUDY
    The Journal of Urology, vol. 173, no. 5, pp. 1701–1705, 2005
  43. THE COST-EFFECTIVENESS OF COMBINED ANDROGEN BLOCKADE WITH BICALUTAMIDE AND LUTEINIZING HORMONE RELEASING HORMONE AGONIST IN MEN WITH METASTATIC PROSTATE CANCER
    Journal of Urology, The, vol. 174, no. 2, pp. 547–552, 2005
  44. LONG-TERM EFFECTS OF FINASTERIDE ON PROSTATE SPECIFIC ANTIGEN LEVELS: RESULTS FROM THE PROSTATE CANCER PREVENTION TRIAL
    Journal of Urology, The, vol. 174, no. 3, pp. 877–881, 2005
  45. LAPAROSCOPIC UROLOGICAL ONCOLOGY: HERE COME THE OUTCOMES!
    Journal of Urology, The, vol. 174, no. 4, pp. 1174–1174, 2005
  46. VALIDATION OF INCREASING PROSTATE SPECIFIC ANTIGEN AS A PREDICTOR OF PROSTATE CANCER DEATH AFTER TREATMENT OF LOCALIZED PROSTATE CANCER WITH SURGERY OR RADIATION
    The Journal of Urology, vol. 171, no. 6, pp. 2221–2225, 2004
  47. THE ECONOMIC BURDEN OF METASTATIC AND PROSTATE SPECIFIC ANTIGEN PROGRESSION IN PATIENTS WITH PROSTATE CANCER: FINDINGS FROM A RETROSPECTIVE ANALYSIS OF HEALTH PLAN DATA
    The Journal of Urology, vol. 171, no. 6, pp. 2250–2254, 2004
  48. LAPAROSCOPIC PARTIAL NEPHRECTOMY AND PROSTATECTOMY: WEIGHING THE COSTS AND THE BENEFITS
    The Journal of Urology, vol. 172, no. 1, pp. 6–7, 2004
  49. RE: THE ECONOMIC BURDEN OF METASTATIC AND PROSTATE SPECIFIC ANTIGEN PROGRESSION IN PATIENTS WITH PROSTATE CANCER: FINDINGS FROM A RETROSPECTIVE ANALYSIS OF HEALTH PLAN DATA
    The Journal of Urology, vol. 172, no. 6, pp. 2484–2484, 2004
  50. An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United States
    American Journal of Epidemiology, vol. 160, no. 11, pp. 1059–1069, 2004
  51. Combining longitudinal studies of PSA
    Biostatistics, vol. 5, no. 3, pp. 483–500, 2004
  52. Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study
    CancerSpectrum Knowledge Environment, vol. 96, no. 18, pp. 1358–1367, 2004
  53. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: Review of epidemiologic literature*1
    Urology, vol. 64, no. 2, pp. 201–211, 2004
  54. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999
    Urology, vol. 64, no. 6, pp. 1171–1176, 2004
  55. Differences in health-related quality of life of prostate cancer patients based on stage of cancer
    Psycho-Oncology, vol. 13, no. 11, pp. 800–807, 2004
  56. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls
    Cancer, vol. 101, no. 9, pp. 2011–2019, 2004
  57. EDITORIAL COMMENT
    The Journal of Urology, vol. 171, no. 2, pp. 707–708, 2004
  58. Racial/Ethnic Differences in Functional Outcomes in the 5 Years After Diagnosis of Localized Prostate Cancer
    Journal of Clinical Oncology, vol. 22, no. 20, pp. 4193–4201, 2004
  59. Erectile Dysfunction in Diabetic Patients
    Diabetes Spectrum, vol. 17, no. 4, pp. 225–230, 2004
  60. Do Impotent Men With Diabetes Have More Severe Erectile Dysfunction and Worse Quality of Life Than the General Population of Impotent Patients?: Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database
    Diabetes Care, vol. 26, no. 4, pp. 1093–1099, 2003
  61. General Quality of Life 2 Years Following Treatment for Prostate Cancer: What Influences Outcomes? Results From the Prostate Cancer Outcomes Study
    Journal of Clinical Oncology, vol. 21, no. 6, pp. 1147–1154, 2003
  62. In Reply:
    Journal of Clinical Oncology, vol. 21, no. 24, pp. 4655-a–4656, 2003
  63. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis
    Cancer, vol. 98, no. 3, pp. 496–503, 2003
  64. Quality of life after treatment for prostate cancer
    Current Urology Reports, vol. 4, no. 3, pp. 185–195, 2003
  65. Editorial comment
    Urologic Oncology: Seminars and Original Investigations, vol. 21, no. 5, p. 353, 2003
  66. The physical burden of prostate cancer
    Urologic Clinics of North America, vol. 30, no. 2, pp. 305–313, 2003
  67. Early Prostate Cancer: Prevention, Treatment Modalities, and Quality of Life Issues
    European Urology, vol. 44, no. 3, pp. 283–293, 2003
  68. Longitudinal Differences in Disease Specific Quality of Life in Men With Erectile Dysfunction: Results From the Exploratory Comprehensive Evaluation of Erectile Dysfunction Study
    The Journal of Urology, vol. 169, no. 4, pp. 1437–1442, 2003
  69. Is Quality if Life Different for Men with Erectile Dysfunction and Prostate Cancer Compared to Men with Erectile Dysfunction Due to Other Causes? Results from the ExCEED Data Base
    The Journal of Urology, vol. 169, no. 4, pp. 1458–1461, 2003
  70. Health Related Quality of Life in Men With Prostate Cancer
    The Journal of Urology, vol. 169, no. 5, pp. 1653–1661, 2003
  71. Sociodemographic and Clinical Risk Characteristics of Patients With Prostate Cancer Within the Veterans Affairs Health Care System: Data From CaPSURE
    The Journal of Urology, vol. 170, no. 3, pp. 905–908, 2003
  72. Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom
    Surgical Oncology, vol. 11, no. 1-2, pp. 3–11, 2002
  73. Symptoms and inflammation in chronic prostatitis/chronic pelvic pain syndrome
    Urology, vol. 60, no. 6, pp. 959–963, 2002
  74. Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
    CancerSpectrum Knowledge Environment, vol. 94, no. 13, pp. 981–990, 2002
  75. EDITORIAL COMMENT
    The Journal of Urology, vol. 168, no. 6, pp. 2504–2504, 2002
  76. The Cost-Effectiveness of Treatment for Varicocele Related Infertility
    The Journal of Urology, vol. 168, no. 6, pp. 2490–2494, 2002
  77. Racial Variation in the Incidence of Squamous Cell Carcinoma of the Bladder in the United States
    The Journal of Urology, vol. 168, no. 5, pp. 1960–1963, 2002
  78. Psychological Impact of Erectile Dysfunction: Validation of a New Health Related Quality of Life Measure for Patients With Erectile Dysfunction
    The Journal of Urology, vol. 168, no. 5, pp. 2086–2091, 2002
  79. How Well Does The Partin Nomogram Predict Pathological Stage After Radical Prostatectomy In A Community Based Population? Results Of The Cancer Of The Prostate Strategic Urological Research Endeavor
    The Journal of Urology, vol. 167, no. 4, pp. 1653–1658, 2002
  80. HEALTH RELATED QUALITY OF LIFE DIFFERENCES BETWEEN BLACK AND WHITE MEN WITH PROSTATE CANCER: DATA FROM THE CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR
    The Journal of Urology, vol. 166, no. 6, pp. 2281–2285, 2001
  81. Determining Cause of Death in Prostate Cancer: Are Death Certificates Valid?
    Journal of the National Cancer Institute, vol. 93, no. 23, pp. 1822–1823, 2001
  82. Men's Health
    Journal of General Internal Medicine, vol. 16, no. 10, pp. 717–718, 2001
  83. Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the ? database
    Urology, vol. 57, no. 3, pp. 499–503, 2001
  84. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer
    Journal of Clinical Epidemiology, vol. 54, no. 4, pp. 350–358, 2001
  85. Men's Health. Are We Missing the Big Picture?
    Journal of General Internal Medicine, vol. 16, no. 10, pp. 717–718, 2001
  86. Quality of life following prostate cancer treatments
    Current Urology Reports, vol. 1, no. 1, pp. 71–77, 2000
  87. DOES SITE SPECIFIC LABELING OF SEXTANT BIOPSY CORES PREDICT THE SITE OF EXTRACAPSULAR EXTENSION IN RADICAL PROSTATECTOMY SURGICAL SPECIMEN?
    The Journal of Urology, vol. 162, no. 4, pp. 1352–1357, 1999
  88. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer
    Prostate Cancer and Prostatic Diseases, vol. 1, no. 3, pp. 134–143, 1998
  89. Health-related quality of life in men with prostate cancer
    Prostate Cancer and Prostatic Diseases, vol. 1, no. 5, pp. 228–235, 1998
  90. Computer-generated graphical presentations: Use of multimedia to enhance communication
    Urology, vol. 49, no. 1, pp. 2–9, 1997
  91. EFFECT OF CRYPTORCHIDISM ON TESTICULAR HISTOLOGY IN A NATURALLY CRYPTORCHID ANIMAL MODEL
    The Journal of Urology, vol. 158, no. 5, pp. 1978–1982, 1997
  92. Adrenal Control of Erectile Function and Nitric Oxide Synthase in the Rat Penis
    Endocrinology, vol. 138, no. 9, pp. 3925–3932, 1997
  93. Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat
    Biology of Reproduction, vol. 55, no. 3, pp. 567–574, 1996
  94. Segmental Testicular Infarction in the Neonate: A Case Report
    The Journal of Urology, vol. 153, no. 6, pp. 1992–1993, 1995